Business Description
eFFECTOR Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US28202V2079
Description
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.15 | |||||
9-Day RSI | 35.95 | |||||
14-Day RSI | 39.59 | |||||
3-1 Month Momentum % | 200 | |||||
6-1 Month Momentum % | 200 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | 0.16 | |||||
EV-to-Forward-EBIT | -0.72 | |||||
EV-to-EBITDA | 0.16 | |||||
EV-to-Forward-EBITDA | -0.72 | |||||
EV-to-FCF | 0.18 | |||||
Earnings Yield (Greenblatt) % | 625 | |||||
FCF Yield % | -2927500 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:EFTR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
eFFECTOR Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -13.08 | ||
| Beta | 4.6703 | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.8 | ||
| Volatility % | 205.73 | ||
| 14-Day RSI | 39.59 | ||
| 14-Day ATR ($) | 0.000159 | ||
| 20-Day SMA ($) | 0.00056 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0002 - 0.01 | ||
| Shares Outstanding (Mil) | 4.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
eFFECTOR Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
eFFECTOR Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.04:1 Stock Split | 2024-01-12 | 9.69 (-9.89%) |
Show
Entries
eFFECTOR Therapeutics Inc Frequently Asked Questions
What is eFFECTOR Therapeutics Inc(EFTR)'s stock price today?
The current price of EFTR is $0.00. The 52 week high of EFTR is $0.01 and 52 week low is $0.00.
When is next earnings date of eFFECTOR Therapeutics Inc(EFTR)?
The next earnings date of eFFECTOR Therapeutics Inc(EFTR) is .
Does eFFECTOR Therapeutics Inc(EFTR) pay dividends? If so, how much?
eFFECTOR Therapeutics Inc(EFTR) does not pay dividend.
Guru Commentaries on OTCPK:EFTR
No articles.
Press Release
Articles on eFFECTOR Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers